Scholars Central

Conference abstractPublished 15 Nov 2021

Biomarkers as Key Drivers of Drug Development in Gene Therapy

Authors: Oscar Segurado

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biomarkers are tools that can facilitate selection and monitoring of gene therapies and their proper identification and application allows patients to be treated accurately, effectively, and safely. Several biomarkers of disease, immune, cellular, and molecular responses to gene therapies are available, and the role of biomarkers will expand as gene therapies continue to develop. Selecting the right patient for the right therapy and monitoring that patient’s response to the therapy is imperative for drug discovery. With the rapid growth of gene therapies, biotechnology and pharmaceutical companies face a call to action: We must establish proper selection and monitoring protocols to provide patients with the safest and most effective therapeutic options for genetic diseases. Precision medicine is changing the way we think about, prevent, treat, and monitor many diseases.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalAmerican Journal of Pharmacology and Pharmacotherapeutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Oscar Segurado”